We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$706B
AUM Growth
-$5.71B
Cap. Flow
-$2.17B
Cap. Flow %
-0.31%
Top 10 Hldgs %
21.49%
Holding
2,592
New
52
Increased
1,566
Reduced
801
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 15.83%
3 Financials 13.92%
4 Consumer Discretionary 13.43%
5 Industrials 10.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILAK icon
526
Liberty Latin America Class C
LILAK
$1.65B
$140M 0.02%
9,594,574
+265,307
+3% +$3.82M
ECL icon
527
Ecolab
ECL
$77.6B
$140M 0.02%
705,511
+4,386
+0.6% +$879K
BPOP icon
528
Popular Inc
BPOP
$11.3B
$140M 0.02%
2,581,220
-295,846
-10% -$16M
SGI
529
Somnigroup International
SGI
$13.6B
$137M 0.02%
7,124,236
-243,620
-3% -$4.67M
PSX icon
530
Phillips 66
PSX
$90.9B
$137M 0.02%
1,340,838
+155,565
+13% +$15.6M
ABMD
531
DELISTED
Abiomed Inc
ABMD
$137M 0.02%
768,595
+477,638
+164% +$103M
JOYY
532
JOYY Inc
JOYY
$3.69B
$135M 0.02%
2,409,423
-175,761
-7% -$10.7M
XLRN
533
DELISTED
Acceleron Pharma
XLRN
$135M 0.02%
3,415,437
-358,676
-10% -$15.6M
PAYC icon
534
Paycom
PAYC
$9.5B
$135M 0.02%
644,023
+241,858
+60% +$56.5M
AGCO icon
535
AGCO
AGCO
$7.05B
$134M 0.02%
1,770,265
-76,252
-4% -$5.6M
HR icon
536
Healthcare Realty
HR
$6.6B
$133M 0.02%
4,540,196
-304,577
-6% -$8.51M
JOE icon
537
St. Joe Company
JOE
$3.9B
$133M 0.02%
7,766,680
+581,705
+8% +$10.3M
FRT icon
538
Federal Realty Investment Trust
FRT
$10.3B
$133M 0.02%
975,655
-148,292
-13% -$19.6M
BBD icon
539
Banco Bradesco
BBD
$34.9B
$132M 0.02%
21,655,375
-2,625,930
-11% -$17.4M
THG icon
540
Hanover Insurance
THG
$7.73B
$131M 0.02%
969,033
+12,351
+1% +$1.62M
AEPPL
541
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
$130M 0.02%
2,365,073
-214,598
-8% -$11.9M
PODD icon
542
Insulet
PODD
$9.95B
$130M 0.02%
788,922
+290,326
+58% +$40.8M
ENSG icon
543
The Ensign Group
ENSG
$10.6B
$130M 0.02%
2,920,449
+1,822
+0.1% +$90.2K
PRAA icon
544
PRA Group
PRAA
$775M
$129M 0.02%
3,831,233
-229,761
-6% -$7.31M
CELG
545
DELISTED
Celgene Corp
CELG
$129M 0.02%
1,302,695
-741,178
-36% -$70.4M
GH icon
546
Guardant Health
GH
$22B
$129M 0.02%
2,022,402
+272,972
+16% +$24M
ABEV icon
547
Ambev
ABEV
$43.9B
$129M 0.02%
27,928,500
+23,644,200
+552% +$113M
BLK icon
548
Blackrock
BLK
$182B
$128M 0.02%
287,888
+2,494
+0.9% +$1.11M
USPH icon
549
US Physical Therapy
USPH
$1.23B
$128M 0.02%
978,835
-75,478
-7% -$9.83M
TCDA
550
DELISTED
Tricida, Inc. Common Stock
TCDA
$128M 0.02%
4,130,746
+229,421
+6% +$7.69M

Similar funds

T. Rowe Price Associates's Q3 2019 Portfolio in Review

As of Q3 2019, T. Rowe Price Associates held 2,592 positions worth $706B, down 0.8% from $712B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Trading was light in Q3 2019: portfolio turnover was 4.9%. T. Rowe Price Associates opened 52 new positions and exited 74, leaving the 2,592-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2019 buy was The Southern Company: 9,440,159 shares worth $502M.
  • T. Rowe Price Associates added most to Fidelity National Information Services in Q3 2019, an estimated $3.15B increase.
  • T. Rowe Price Associates's biggest Q3 2019 reduction was Bank of America, cutting an estimated $1.43B.
  • T. Rowe Price Associates fully exited Worldpay, Inc. in Q3 2019, selling an estimated $3.23B.
  • T. Rowe Price Associates's ten largest holdings make up 21% of its $706B portfolio in Q3 2019.
  • T. Rowe Price Associates opened 52 new positions and closed 74 in Q3 2019.
  • T. Rowe Price Associates's portfolio value fell 0.8% quarter-over-quarter to $706B.

Based on T. Rowe Price Associates's 13F filing for Q3 2019, filed 14 Nov 2019.